Hangzhou Minsheng Pharmaceutical Group Co., Ltd.
http://www.mspharm.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Hangzhou Minsheng Pharmaceutical Group Co., Ltd.
Game Of Thrones: Bayer Looks To Lead China’s OTC Market
The recent acquisition of Dihon Pharmaceutical Group marks progress toward Bayer’s goal of becoming the leader in the OTC sector in China. Dihon provides an entry into the TCM arena, which makes up about half of the OTC segment in China, the firm says.
Game Of Thrones: Bayer Looks To Lead China’s OTC Market
The recent acquisition of Dihon Pharmaceutical Group marks progress toward Bayer’s goal of becoming the leader in the OTC sector in China. Dihon provides an entry into the TCM arena, which makes up about half of the OTC segment in China, the firm says.
Game Of Thrones: Bayer Looks To Lead China’s OTC Market
After the recent acquisition of a local OTC firm, PharmAsia News takes a closer look at Bayer’s aims of becoming the leader in the OTC sector in China.
Deals Shaping The Medical Industry, January 2013
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Pharmaceuticals, and Medical Devices – and then categorized by type –Acquisition, Alliance, or Financing.
Company Information
- Industry
-
Pharmaceuticals
- Nutraceuticals
- OTC, Consumer
-
Biotechnology
-
Drug Discovery Tools
-
Molecular Diversity
- Natural Products
-
Molecular Diversity
-
Drug Discovery Tools
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice